Testicular Yolk Sac Tumor
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Testicular Yolk Sac Tumor

What is the definition of Testicular Yolk Sac Tumor?
Testicular yolk sac tumor is a subtype of testicular cancer that most commonly occurs in the testicles of young and middle-age men. While the exact cause is not well understood, some risk factors have been determined, such as undescended testicle, abnormal testicle development, smoking, exposure to some chemicals, family history of testicular cancer, HIV infection, and Down syndrome.
What are the symptoms of Testicular Yolk Sac Tumor?
Testicular yolk sac tumor may have no symptoms or appear as a painless mass in the testes. If symptoms occur, they may include discomfort or pain, or a sense of heaviness in the scrotum, lower back of abdominal pain, an enlarged testicle, or an overgrowth of male breast tissue. The cancer may spread to other parts of the body.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Testicular Yolk Sac Tumor?
Treatment for testicular yolk sac cancer depends on how far the cancer has spread and includes surgery (removal of the testicle), radiation therapy, and chemotherapy. Testicular yolk sac cancer is highly treatable and has a high rate of success. Testicular cancer can be detected early by performing a monthly testicular self-examination.
Who are the top Testicular Yolk Sac Tumor Local Doctors?
Elizabeth V. Connor
Advanced in Testicular Yolk Sac Tumor
Advanced in Testicular Yolk Sac Tumor

St. Vincent Regional Hospital - Cancer Centers Of Montana

1315 Golden Valley Circle, 
Billings, MT 
Experience:
14+ years
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Dr. Connor completed an undergraduate degree in Biochemistry at the University of Virginia and later earned her Medical Doctorate at the University of Virginia School of Medicine. She then completed her Obstetrics & Gynecology Residency training at Brown University and Gynecologic Oncology fellowship training at the Cleveland Clinic. She is board-certified in both obstetrics and gynecology and gynecologic oncology. Her clinical interests include preventing, diagnosing, and treating ovarian, uterine, cervical, vaginal and vulvar cancers. Dr. Connor moved to Montana to ensure comprehensive access to gynecologic oncology services in the region.“I care deeply for my patients and work hard for them to have the highest level of care and autonomy in their care.”When not seeing patients, Dr. Connor spends her time with her husband, two children, and two family dogs. They spend most of their time outside, whether skiing, hiking, or catching a soccer game. Dr. Connor is rated as an Advanced provider by MediFind in the treatment of Testicular Yolk Sac Tumor. Her top areas of expertise are Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Bladder Reconstruction.

Norman G. Rosenblum
Advanced in Testicular Yolk Sac Tumor
Oncology | Obstetrics and Gynecology
Advanced in Testicular Yolk Sac Tumor
Oncology | Obstetrics and Gynecology

Jefferson Obstetrics And Gynecology

833 Chestnut Street, 1st, Floor, 
Philadelphia, PA 
Languages Spoken:
English

. Dr. Rosenblum is rated as an Advanced provider by MediFind in the treatment of Testicular Yolk Sac Tumor. His top areas of expertise are Endometrial Cancer, Vulvar Cancer, Sertoli-Leydig Cell Tumor, Hernia Surgery, and Hysterectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Scott Kamelle
Advanced in Testicular Yolk Sac Tumor
Advanced in Testicular Yolk Sac Tumor

Aurora Gynecologic Oncology

8905 W Lincoln Ave, Ste 407, 
West Allis, WI 
Languages Spoken:
English

Scott Kamelle is an Oncologist in West Allis, Wisconsin. Dr. Kamelle is rated as an Advanced provider by MediFind in the treatment of Testicular Yolk Sac Tumor. His top areas of expertise are Endometrial Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Ureteroscopy, and Bladder Reconstruction.

What are the latest Testicular Yolk Sac Tumor Clinical Trials?
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Selected Advanced or Metastatic Solid Tumors

Summary: This is a first-in-human (FIH) clinical study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and anti-tumor activity of BGB-B2033 administered as monotherapy and in combination with tislelizumab, with or without bevacizumab. The study will enroll participants with locally advanced or metastatic hepatocellular carcinoma (HCC), alpha-fetoprotein (AFP)-pr...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor

Summary: This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other parts of the brain or body (localized). This study has 2 goals: 1) optimizing radiation for patients who respond well to induction chemotherapy to diminish...